| |
| |
|
| Insider
Information: |
Hsiao Jane Ph D |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
49,658,203 |
|
|
Indirect Shares
|
33,836,183 |
|
|
| Direct
Value |
$46,236,525 |
|
|
|
Indirect Value
|
$19,384,145 |
|
|
| Total
Shares |
83,494,386 |
|
|
| Total
Value |
$65,620,669 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
3.0
|
0.0
|
| Percentage
Gain/Loss : |
 12.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Asensus Surgical Inc |
ASXC |
Director |
2021-07-01 |
336,895 |
2021-07-01 |
96,746 |
Premium* |
|
|
Protalix Biotherapeutics |
PLX |
Director |
2007-01-31 |
1,134,060 |
|
0 |
Premium* |
|
|
Opko Health Inc |
OPK |
|
2024-01-17 |
27,999,880 |
2024-01-17 |
5,127,404 |
Premium* |
|
|
Prolor Biotech Inc |
PBTH |
Director |
2013-08-29 |
0 |
2013-08-29 |
0 |
Premium* |
|
|
Non Invasive Monitoring Systems ... |
NIMU |
Interim CEO, Director,... |
2018-12-21 |
16,752,074 |
2018-12-21 |
20,883,660 |
Premium* |
|
|
Sorrento Therapeutics Inc |
SRNE |
Director |
|
0 |
2010-01-25 |
2,231,719 |
Premium* |
|
|
Cocrystal Pharma |
COCP |
|
2016-03-15 |
3,435,294 |
2016-03-15 |
5,496,654 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ASXC |
Asensus Surgical Inc |
Director |
– • – |
2021-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
29,231 |
336,895 |
0 |
- |
|
| NIMU |
Non Invasive Monitoring S... |
Interim CEOChairman of the Boa |
• • • |
2013-04-08 |
4 |
B |
$0.05 |
$1,000,000 |
D/D |
20,000,000 |
10,400,000 |
3.23 |
- |
|
| NIMU |
Non Invasive Monitoring S... |
Interim CEOChairman of the Boa |
• • • |
2013-04-08 |
4/A |
B |
$0.05 |
$100,000 |
D/D |
2,000,000 |
10,400,000 |
3.23 |
- |
|
| NIMU |
Non Invasive Monitoring S... |
Interim CEO |
• • • |
2018-12-21 |
4 |
B |
$0.07 |
$1,461,856 |
I/I |
20,883,660 |
20,883,660 |
2.64 |
- |
|
| NIMU |
Non Invasive Monitoring S... |
Interim CEO |
• • • |
2018-12-21 |
4 |
B |
$0.07 |
$444,645 |
D/D |
6,352,074 |
16,752,074 |
3.23 |
- |
|
| ASXC |
Asensus Surgical Inc |
Chairman of the Board |
– • • |
2012-10-25 |
4 |
OE |
$0.25 |
$196,346 |
I/I |
785,383 |
785,383 |
0 |
- |
|
| ASXC |
Asensus Surgical Inc |
Chairman of the Board |
– • • |
2013-03-22 |
4 |
B |
$0.25 |
$1,000,000 |
D/D |
4,000,000 |
11,437,681 |
3.92 |
- |
|
| ASXC |
Asensus Surgical Inc |
Chairman of the Board |
– • • |
2012-02-17 |
4 |
B |
$0.40 |
$1,800,000 |
D/D |
4,500,000 |
7,303,965 |
3.92 |
- |
|
| ASXC |
Asensus Surgical Inc |
Director |
– • – |
2013-12-06 |
4 |
OE |
$0.40 |
$1,750,000 |
I/I |
4,375,000 |
6,288,470 |
0 |
- |
|
| ASXC |
Asensus Surgical Inc |
Director |
– • – |
2013-12-06 |
4 |
OE |
$0.40 |
$1,750,000 |
D/D |
4,375,000 |
15,812,681 |
0 |
- |
|
| PBTH |
Prolor Biotech Inc |
Director |
– • – |
2010-05-20 |
4 |
OE |
$0.50 |
$380,000 |
D/D |
760,000 |
1,811,333 |
0 |
- |
|
| COCP |
Cocrystal Pharma |
|
– • – |
2016-03-15 |
4 |
B |
$0.51 |
$630,000 |
D/D |
1,235,294 |
3,435,294 |
2.39 |
- |
|
| OPK |
Opko Health Inc |
Vice Chairman & CTO |
• • – |
2014-08-01 |
4 |
OE |
$0.66 |
$1,485,533 |
D/D |
309,583 |
21,647,795 |
0 |
- |
|
| OPK |
Opko Health Inc |
Vice Chairman & CTO |
• • – |
2015-01-31 |
4 |
OE |
$0.67 |
$2,512,440 |
D/D |
2,936,580 |
24,584,375 |
0 |
- |
|
| OPK |
Opko Health Inc |
Vice Chairman & CTO |
• • – |
2024-01-05 |
4 |
B |
$0.87 |
$130,899 |
D/D |
150,010 |
27,849,880 |
0.01 |
% |
|
| COCP |
Cocrystal Pharma |
|
– • – |
2015-03-25 |
4 |
B |
$0.92 |
$2,024,000 |
D/D |
2,200,000 |
2,200,000 |
2.39 |
- |
|
| OPK |
Opko Health Inc |
Vice Chairman & CTO |
• • – |
2024-01-17 |
4 |
B |
$0.95 |
$142,500 |
D/D |
150,000 |
27,999,880 |
0.01 |
% |
|
| PBTH |
Prolor Biotech Inc |
Director |
– • – |
2010-05-20 |
4 |
OE |
$1.00 |
$368,523 |
I/I |
368,523 |
2,179,856 |
0 |
- |
|
| ASXC |
Asensus Surgical Inc |
Chairman of the Board |
– • • |
2010-06-15 |
4 |
B |
$1.00 |
$1,300,000 |
I/I |
1,300,000 |
1,360,000 |
2.25 |
- |
|
| ASXC |
Asensus Surgical Inc |
Chairman of the Board |
– • • |
2010-09-10 |
4 |
OE |
$1.00 |
$477,209 |
I/I |
477,209 |
1,837,209 |
0 |
- |
|
| OPK |
Opko Health Inc |
See Remarks |
• • – |
2008-08-08 |
4 |
A |
$1.11 |
$1,999,998 |
I/I |
1,801,800 |
2,354,800 |
0 |
- |
|
| OPK |
Opko Health Inc |
Vice Chairman & CTO |
• • – |
2013-12-13 |
4 |
OE |
$1.16 |
$4,729,000 |
D/D |
1,537,500 |
21,308,212 |
0 |
- |
|
| OPK |
Opko Health Inc |
Vice Chairman and CTO |
• – – |
2008-07-02 |
4 |
B |
$1.24 |
$69,517 |
I/I |
53,000 |
553,000 |
1.99 |
- |
|
| OPK |
Opko Health Inc |
Vice Chairman and CTO |
• • – |
2008-05-08 |
4 |
B |
$1.25 |
$625,000 |
I/I |
500,000 |
500,000 |
2.66 |
- |
|
| OPK |
Opko Health Inc |
Vice Chairman & CTO |
• • – |
2023-11-10 |
4 |
B |
$1.26 |
$126,659 |
D/D |
100,000 |
27,699,870 |
2.81 |
% |
|
93 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
